Cell and Gene Therapy Services Market
Updated Date: 27 July 2026   |   Report Code: 6575
sales@towardshealthcare.com +1 804-441-9344
Download Sample Order Now

Cell And Gene Therapy Services Market Trends, Growth, and Market Size Analysis 2035

According to Payal Rabde, who specializes in manufacturing services including process development, scale-up and GMP production, cell processing, viral vector production, cryopreservation, storage, and cold-chain logistics, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the cell and gene therapy services market. The global cell and gene therapy service market size was estimated at USD 10.79 billion in 2025 and is predicted to increase from USD 11.84 billion in 2026 to approximately USD 27.16 billion by 2035, expanding at a CAGR of 9.67% from 2026 to 2035. Her analysis highlights the increasing adoption of personalized and precision medicine, expanding clinical trials and approvals for cell and gene therapies, rising investments from pharmaceutical, biotechnology, and contract development and manufacturing organizations (CDMOs), and strong regulatory support and increasing public-private funding for advanced therapy development. The research also examines the competitive strategies of key industry participants, including, Lonza, Thermo Fisher Scientific, Catalent, WuXi App Tec, AGC Biologics, Charles River Laboratories, and Intellia Therapeutics, shaping the future by advancing personalized and curative treatment approaches through innovation cell and gene therapies,  expanding automation, AI-driven analytics, and digital manufacturing to improve efficiency and scalability, strengthening the decentralized manufacturing, cold-chain logistics, and global supply chain networks, and increasing strategic collaborations among pharmaceutical companies, biotechnology firms, CDMOs, and research institutions to drive innovation and commercialization in the global cell and gene therapy services market.

Last Updated : 27 July 2026 Category: Therapeutic Area Insight Code: 6575 Format: PDF / PPT / Excel

Content

Chapter 1: Introduction

  • Market Definition & Taxonomy
  • Research Objectives
  • Market Scope & Assumptions
  • Study Timeline (Historical, Base Year, Forecast Period)
  • Key Stakeholders Covered

Chapter 2: Research Methodology

  • Research Framework Overview
  • Market Size Estimation Methodology
    • Bottom-Up Approach
    • Top-Down Approach
  • Forecasting Model
    • Dependent Variables
    • Independent Variables
    • Key Assumptions & Weightages
  • Primary Research Insights
  • Secondary Data Sources
  • Data Validation & Triangulation

Chapter 3: Executive Summary

  • Global & Regional Overview (Value, CAGR)
  • Epidemiology Snapshot
  • Segmental Overview
  • Competition Key Snippets
  • Strategic Takeaways

Chapter 4: Market Catalysts, Constraints & Growth Levers

  • Market Dynamics
  • Market Drivers/Catalysts
    • Driver 1
    • Driver 2
  • Market Restraints
    • Restraint 1
    • Restraint 2
  • Market Opportunities
    • Opportunity 1
    • Opportunity 2
  • Market Trends
    • Trend 1
    • Trend 2
  • Impact Assessment of Drivers, Restraints, Opportunities & Trends (High, Mid, & Low)

Chapter 5: Value Added Intelligence

  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers: Low/Moderate/High
    • Bargaining Power of Buyers: Low/Moderate/High
    • Threat of New Entrants: Low/Moderate/High
    • Threat of Substitute: Low/Moderate/High
    • Competitive Rivalry: Low/Moderate/High
  • PESTEL Analysis
  • Ecosystem Analysis
  • Mapping of Key Players
  • Value Chain Analysis
  • Margin Analysis Across Value Chain
  • Macro & Micro Factors Impacting Market
  • Market Potential Evaluation, By Region
  • Epidemiology & Patient Pool Analysis
    • Disease Incidence & Prevalence
    • Target Patient Pool
      • Diagnosed Population
      • Service-Seeking Population
    • Patient Flow & Utilization Analysis
      • Patient Footfall
      • Admission Rates
      • Procedure Volume
    • Healthcare Infrastructure Analysis
      • Number of Facilities
        • Hospitals
        • Clinics
        • Diagnostic Centers
        • ASCs
      • Bed Capacity
        • Total Beds
        • ICU Beds
      • Facility Distribution
    • Operational Metrics Analysis
      • Bed Occupancy Rate (%)
      • Average Length of Stay (ALOS)
    • Service Pricing & Revenue Model
      • Pricing Analysis
        • Cost per Procedure
        • Cost per Consultation
        • Cost per Diagnostic Test
      • Revenue Streams
        • Inpatient Services
        • Outpatient Services
        • Ancillary Services
      • Workforce & Staffing Analysis
        • Healthcare Workforce
          • Physicians
          • Nurses
          • Technicians
        • Staff-to-Patient Ratios
        • Skill Gap Analysis
        • Labor Cost Structure
      • Scenario Analysis (Base / Optimistic / Pessimistic)
      • Risk Assessment & Sensitivity Analysis
      • Opportunity Analysis, By Region
      • Regulatory Analysis
      • Sustainability & ESG Insights
      • Business Models
      • Investment & Funding Landscape
      • Key Conferences and Events

Chapter 7: Segmental & Regional Analysis

  • Global Cell and Gene Therapy Services Market Analysis, By Service Type
    • Market Size, Forecast & CAGR, By Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Cell and Gene Therapy Services Market Analysis, By Therapy Type
    • Market Size, Forecast & CAGR, By Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Cell and Gene Therapy Services Market Analysis, By Phase of Development
    • Market Size, Forecast & CAGR, By Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Cell and Gene Therapy Services Market Analysis, By End User
    • Market Size, Forecast & CAGR, By Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Cell and Gene Therapy Services Market Analysis, By Delivery Mode
    • Market Size, Forecast & CAGR, By Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Cell and Gene Therapy Services Market Analysis, By Region
    • Market Size, Forecast & CAGR, By Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Cell and Gene Therapy Services Market Analysis
  • North America Cell and Gene Therapy Services Market Analysis, By Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Cell and Gene Therapy Services Market Analysis, By Therapy Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Cell and Gene Therapy Services Market Analysis, By Phase of Development, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Cell and Gene Therapy Services Market Analysis, By End User, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Cell and Gene Therapy Services Market Analysis, By Delivery Mode, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Cell and Gene Therapy Services Market Analysis, By Country, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
      • U. S. Cell and Gene Therapy Services Market Analysis
    • U. S. Cell and Gene Therapy Services Market Analysis, By Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U. S. Cell and Gene Therapy Services Market Analysis, By Therapy Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U. S. Cell and Gene Therapy Services Market Analysis, By Phase of Development, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U. S. Cell and Gene Therapy Services Market Analysis, By End User, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U. S. Cell and Gene Therapy Services Market Analysis, By Delivery Mode, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis

Similar Analysis will be given for each country and each region

  • Canada
  • Mexico
  • Rest of North America

Europe

  • Western Europe
  • Germany
  • Italy
  • France
  • Spain
  • UK
  • Netherlands
  • Switzerland
  • Nordic Countries
  • Rest of Western Europe
  • Eastern Europe
  • Austria
  • Russia & Belarus
  • Poland
  • Türkiye
  • Rest of Eastern Europe

Asia Pacific

  • China
  • Taiwan
  • India
  • Japan
  • Vietnam
  • Australia and New Zealand
  • ASEAN Countries
  • South Korea
  • Rest of APAC

South America

  • Brazil
  • Argentina
  • Rest of South America

Middle East and Africa (MEA)

  • GCC Countries
  • South Africa
  • Egypt
  • Rest of MEA

Chapter 6: Competitive Insights

  • Competitive Analysis
    • Company Evaluation Matrix
      • Major Players
      • Mid-Sized Companies
      • Emerging Players/Start-Ups
    • Global Market Share Analysis, By Region, 2025 (%)
    • Key Player Positioning
    • Competitive Benchmarking
      • By Service Type
      • By Therapy Type
      • By Phase of Development
      • By End User
      • By Delivery Mode
    • Strategies of Key Players
    • Insight From the Horse’s Mouth
  • Company Profiles
    • Lonza
      • Company Name
      • Company Headquarters
      • Management Overview
        • Key C-Suite Executives
          • CEO
          • MD
          • Others
        • Employee Count
        • Business Strategy
          • Key Investments Made
          • Future Plans
          • R&D & Innovation Capabilities
          • Recent Developments
            • New Product Launch
            • Merger & Acquisitions
            • Partnerships & Collaborations
            • Market Expansion
            • Others
          • Service Portfolio
          • Facility Network
            • Number of Facilities
            • Bed Capacity
            • Facility Distribution
            • Expansion Pipeline
          • Key Financials (2022-2025)
            • Revenue By Segment
            • Revenue By Service
            • Revenue By Geography
            • Financial Matrix (Gross Profit Margins, Net Margins, etc.)
          • Key Clients
            • Client Company Name
            • Key Contact Person
            • Contact Details
          • Regulatory & Certification Expertise
          • SWOT Analysis
    • Thermo Fisher Scientific 
    • Catalent
    • WuXi App Tec
    • FUJIFILM Diosynth Biotechnologies
    • AGC Biologics
    • Novartis
    • Charles River Laboratories
    • Intellia Therapeutics
    • IQVIA

FAQ's

Answer : The cell and gene therapy services market currently in 2026 records USD 11.84 billion and is anticipated to grow to USD 27.16 billion by 2035, advancing at a CAGR of 9.67% from 2026 to 2035.

Answer : North America is currently leading the cell and gene therapy services market due to the expanding technological advances & R&D expenses on CGT. 

Answer : Key trends include the progression of gene therapy, growth in automated services, and the revolutions in combination therapies & commercial manufacturing. 
Any Questions

Meet the Team

Payal Rabde is a Healthcare Market Research Analyst at Towards Healthcare Research & Consulting with 4+ years of experience in pharmaceuticals, biotechnology, medical devices, and life sciences.

Learn more about Payal Rabde

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar